Arti-Cell Forte
chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells
Table of contents
Overview
Arti-Cell Forte is a veterinary medicine used to treat mild to moderate lameness linked to non-infective joint inflammation in horses. It contains stem cells which are obtained from equine blood. Stem cells can develop into other types of cells. The stem cells in the active substance (mesenchymal stem cells) are treated so that they develop into cartilage cells.
Authorisation details
Product details | |
---|---|
Name |
Arti-Cell Forte
|
Agency product number |
EMEA/V/C/004727
|
Active substance |
chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells
|
International non-proprietary name (INN) or common name |
chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells
|
Species |
Horses
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QM09AX90
|
Publication details | |
---|---|
Marketing-authorisation holder |
Boehringer Ingelheim Vetmedica GmbH
|
Revision |
5
|
Date of issue of marketing authorisation valid throughout the European Union |
29/03/2019
|
Contact address |
Binger Strasse 173 |
Product information
22/10/2021 Arti-Cell Forte - EMEA/V/C/004727 - IAIN/0009/G
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Therapeutic indication
Reduction of mild to moderate recurrent lameness associated with non-septic joint inflammation in horses.